1 / 10

Global Immunosuppressive Drug Market Research and Forecast 2018-2023

Immunosuppressive drugs are used for the treatment of end-stage organ replacement or failure. These drugs are anti-rejection drugs used to make the body less likely to reject a transplanted organ, such as a liver, heart, or kidney. Increasing incidence of chronic ailments and the demand for organ replacement is expected to drive the growth of the market. In addition, growing adoption of tissues engineering in organ transplant also significantly contributing to the market growth. However, high drug cost and a shortage of organ donor for transplant are major restraining factors which may affect the growth of immunosuppressive drug market. Currently, the adoption of newer medication option such as scleroderma treatment and increased use of tissue engineering, which enable in the generation of organs has brought new opportunity to immunosuppressive drug market.

omrglobal
Télécharger la présentation

Global Immunosuppressive Drug Market Research and Forecast 2018-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research GLOBAL IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND FORECAST 2018-2023 Global immunosuppressive drug market size, share, market intelligence, company profiles, market trends, growth, strategy, research and analysis report, forecast 2018-2023

  2. DEFINITION Immunosuppressive drugs are used for the treatment of end- stage organ replacement or failure. These drugs are anti- rejection drugs used to make the body less likely to reject a transplanted organ, such as a liver, heart, or kidney.

  3. MARKET MOTIVATORS • Growing incidence of chronic diseases resulting in organ failure • Advancement in organ transplant & tissue engineering • Dominance of key market player • Extensive clinical studies and R&D activities

  4. MARKET RESTRAINTS • High cost of procedure • Lack of organs donors for transplant

  5. MARKET OPPORTUNITIES • Newer medication option • Increasing used of tissue engineering for implant generation

  6. MARKET SEGMENTATION

  7. MARKET SEGMENTATION BY DRUG TYPE • Antibodies • Calcineurin inhibitor • Antiproliferative agent • Motor inhibitors • Steroids

  8. REGIONAL OVERVIEW

  9. MARKET PLAYERS • AbbVie Inc, • Actiza Pharmaceutical • Astellas Pharma, Inc. • Bristol-Myers Squibb company • GlaxoSmithKline PLC • F. Hoffmann-La Roche Ltd. • Sanofi S.A. • Pfizer, Inc. To Be Continued……

  10. FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com https://www.omrglobal.com/industry-reports/immunosuppressive-drug-market/

More Related